Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Afsaneh Madah Safaei Torogh
Afsaneh Madah Safaei Torogh

Assistant Professor of Radiation Oncology

Department Radiotherapy

School of Medicine

Imam Khomeini Hospital Complex,Cancer Institute

Tehran University of Medical Sciences

All Documents
1. Phase Ii Randomized Trial of 41.4 Gy Vs. 50.4 Gy in Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer, Clinical and Translational Radiation Oncology (2026)
2. Hypofractionated Versus Standard Chemoradiotherapy in the Definitive Treatment of Uterine Cervix Cancer: Interim Results of a Randomized Controlled Clinical Trial, Journal of Cancer Research and Clinical Oncology (2025)
3. Implications for Pelvic Lymph Node Irradiation in Definitive Chemoradiotherapy of Node Negative Muscle Invasive Bladder Cancer Based on Predictive Factors of Clinicopathologic Discrepancy, Journal of Cancer Research and Clinical Oncology (2023)
4. A Dosimetric Evaluation of a High Dose Rate Cobalt-60 Brachytherapy Source Using Shielded, Single and Multi-Channel Cylinder Applicators for Gynecological Cancers, Medical Dosimetry (2022)
5. Evaluation of Survival Rate and Associated Factors in Patients With Cervical Cancer: A Retrospective Cohort Study, Journal of Research in Health Sciences (2022)
6. Detection of the Early Cardiotoxic Effects of Doxorubicin-Containing Chemotherapy Regimens in Patients With Breast Cancer Through Novel Cardiac Magnetic Resonance Imaging: A Short-Term Follow-Up, Journal of Clinical Imaging Science (2021)
7. The Role of Cardiac Magnetic Resonance Imaging in the Detection and Monitoring of Cardiotoxicity in Patients With Breast Cancer After Treatment: A Comprehensive Review, Heart Failure Reviews (2021)
8. Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients With Endometrial Cancer, Asian Pacific Journal of Cancer Prevention (2019)
9. Outcomes of Definitive Chemoradiotherapy for Cervical and Upper Thoracic Esophageal Cancers: A Single-Institution Experience of a Rare Cancer, Journal of Gastrointestinal Cancer (2019)
10. Concurrent Chemo- Radiobrachytherapy With Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer, Asian Pacific Journal of Cancer Prevention (2018)
11. Demographic Characteristics and Prognostic Factors in Pediatric-Type Sarcomas; a 7 Year Single Institutional Experience and Comprehensive Review of the Current Literature, International Journal of Radiation Research (2018)
12. Addition of Oxaliplatin to Neoadjuvant Radiochemotherapy in Mri-Defined T3, T4 or N+ Rectal Cancer: A Randomized Clinical Trial, Asia-Pacific Journal of Clinical Oncology (2017)
13. High-Dose-Rate Intraluminal Brachytherapy Prior to External Radiochemotherapy in Locally Advanced Esophageal Cancer: Preliminary Results, Journal of Contemporary Brachytherapy (2017)
14. How Accurate Is Mri to Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer?, Tehran University Medical Journal (2016)
15. Radiotherapy for Ewing Sarcoma: A 5 Year Experience From Iran Cancer Institute, International Journal of Radiation Research (2016)
16. Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Cancer: Phase Ii Clinical Trial, International Journal of Radiation Research (2015)
17. The Role of Demographic Features, Pathologic Subtype and Classifications on Prognosis in Patients With Rhabdomyosarcoma Referred to Iran Cancer Institute, International Journal of Radiation Research (2015)
18. Ultrasound-Guided Boost Irradiation of Tumor Cavity After Lumpectomy in Breast Cancer, International Journal of Radiation Research (2015)